7Baggers
 Technical Reactions to CVKD Trends in Macro Strategies  news.stocktradersdaily.com Tue, 11 Nov 2025 22:56:03 GMT
 Cadrenal Therapeutics, Inc. SEC 10-Q Report  TradingView Mon, 10 Nov 2025 11:23:00 GMT
 From Vet to Executive: Quang Pham  Orange County Business Journal Sat, 08 Nov 2025 06:29:08 GMT
 cadrenal therapeutics, inc.  Yahoo Finance Sat, 08 Nov 2025 06:27:00 GMT
 from vet to executive  Orange County Business Journal Fri, 07 Nov 2025 21:48:25 GMT
 Cadrenal Therapeutics, Inc.  Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
 cadrenal therapeutics elects new director at meeting  MSN Mon, 03 Nov 2025 16:27:23 GMT
 amazon.com (nasdaq:amzn) hits new 1-year high on earnings beat  Defense World Sat, 01 Nov 2025 06:09:37 GMT
 united therapeutics (nasdaq:uthr) ceo sells $1,696,240.00 in stock  Defense World Thu, 30 Oct 2025 08:45:39 GMT
 cadrenal therapeutics executives sell shares  TradingView Tue, 28 Oct 2025 21:10:00 GMT
 cvkd cfo reports 3,600-share sale; 9,933 shares remain  Stock Titan Tue, 28 Oct 2025 21:00:04 GMT
 cvkd insider quang pham reports sales under rule 10b5‑1 plan  Stock Titan Tue, 28 Oct 2025 21:00:02 GMT

Cadrenal Therapeutics
(NASDAQ:CVKD) 

CVKD stock logo

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fib...

Founded: 2022
IPO Price: $5 (Jan 20, 2023)
Full Time Employees: 1
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends